Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time
Teva Identifier
C33237/3080
ClinicalTrials.gov Identifier
NCT01223365
Study Status
Completed
Trial Condition(s)
Chronic Pain
Interventions
Drug: Hydrocodone ER
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
You are about to leave the Teva Pharmaceuticals global website
The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy policy and terms of use of the websites that you visit.
Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.